Abstract
In most areas of medicine, biological tests are routinely used to assist diagnosis and treatment allocation. However, this is not the case in psychiatry, which is now one of the last areas of medicine where diseases are still diagnosed based on symptoms and biological tests to assist treatment allocation remain to be developed. Heterogeneity is widely recognized as a major challenge toward achieving these objectives and many approaches to tackle such heterogeneity have been proposed over the years, largely aiming to partition psychiatric disorders into more consistent subtypes. However, none of these stratifications have translated toward clinical practice. Here, we review the different approaches employed, focusing on methods that use biological measures to stratify psychiatric disorders. We highlight several recent prominent studies and identify key challenges for the field. Specifically, we argue that a lack of validation or replication of prospective stratifications coupled with a widespread fixation on finding sharply defined subtypes has impeded progress. We outline recently proposed methodological innovations that may be useful to move forward. Many of these innovations provide inferences at the level of individual participants and do not rest on the assumption that the biological fingerprints underlying psychiatric disorders can be cleanly separated into subtypes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barch DM (2017) Biotypes: promise and pitfalls. Biol Psychiatry 82:2–3
Bedi G, Carillo F, Cecchi G, Sezak GF, Sigman M, Mota N, Ribeiro S, Javitt DC, Copelli M, Corcoran CM (2015) Automated analysis of free speech predicts psychosis onset in high-risk youths. Schizophrenia 1:15030
Beirlant J, Goegebeur Y, Teugels J, Segers J (2004) Statistics of extremes: theory and applications. Wiley, Sussex
Betancur C (2011) Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380:42–77
Blei DM, Ng AY, Jordan MI (2003) Latent Dirichlet allocation. J Mach Learn Res 3:993–1022
Boser B, Guyon I, Vapnik V (1992) A training algorithm for optimal margin classifiers. Proceedings of the fifth annual workshop on computational learning theory, vol 5, pp 144–152
Brodersen KH, Deserno L, Schlagenhauf F, Lin Z, Penny WD, Buhmann JM, Stephan KE (2014) Dissecting psychiatric spectrum disorders by generative embedding. Neuroimage Clin 4:98–111
Cannon TD (2016) Deciphering the genetic complexity of schizophrenia. JAMA Psychiat 73:5–6
Clementz BA, Sweeney JA, Hamm JP, Ivleva EI, Ethridge LE, Pearlson GD, Keshavan MS, Tamminga CA (2016) Identification of distinct psychosis biotypes using brain-based biomarkers. Am J Psychiatry 173:373–384
Costa Dias TG, Iyer SP, Carpenter SD, Cary RP, Wilson VB, Mitchell SH, Nigg JT, Fair DA (2015) Characterizing heterogeneity in children with and without ADHD based on reward system connectivity. Dev Cogn Neurosci 11:155–174
Dong AY, Honnorat N, Gaonkar B, Davatzikos C (2016) CHIMERA: clustering of heterogeneous disease effects via distribution matching of imaging patterns. IEEE Trans Med Imaging 35:612–621
Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A, Voss HU, Casey BJ, Dubin MJ, Liston C (2017) Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 23:28–38
Gates KM, Molenaar PCM, Iyer SP, Nigg JT, Fair DA (2014) Organizing heterogeneous samples using community detection of GIMME-derived resting state functional networks. PLoS One 9(3):e91322
Hastie T, Tibshirani R, Friedman J (2009) The elements of statistical learning. Springer, New York
Honnorat J, Dong A, Meizenzahl-Lechner E, Koutsoleris N, Davatzikos C (2018) Neuroanatomical heterogeneity of schizophrenia revealed by semi-supervised machine learning methods. In press
Insel TR (2014) Mental disorders in childhood shifting the focus from behavioral symptoms to neurodevelopmental trajectories. JAMA 311:1727–1728
Insel TR, Cuthbert BN (2015) Brain disorders? Precisely. Science 348:499–500
Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C, Wang P (2010) Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 167:748–751
Ivleva EI, Clementz BA, Dutcher AM, Arnold SJM, Jeon-Slaughter H, Aslan S, Witte B, Poudyal G, Lu H, Meda SA, Pearlson GD, Sweeney JA, Keshavan MS, Tamminga CA (2017) Brain structure biomarkers in the psychosis biotypes: findings from the bipolar-schizophrenia network for intermediate phenotypes. Biol Psychiatry 82:26–39
Kalia M (2015) Biomarkers for personalized oncology: recent advances and future challenges. Metabolism 64:S16–S21
Kapur S, Phillips AG, Insel TR (2012) Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry 17:1174–1179
Kriegel H-P, Kroeger P, Zimek A (2009) Clustering high-dimensional data: a survey on subspace clustering, pattern-based clustering, and correlation clustering. ACM Trans Knowl Discov Data 3:1–58
Lamers F, Vogelzangs N, Merikangas KR, De Jonge P, Beekman ATF, Penninx BWJH (2013) Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry 18:692–699
Lecun Y, Bengio Y, Hinton G (2015) Deep learning. Nature 521:436–444
Liu Y, Hayes DN, Nobel A, Marron JS (2008) Statistical significance of clustering for high-dimension, low-sample size data. J Am Stat Assoc 103:1281–1293
Marquand AF, Rezek I, Buitelaar J, Beckmann CF (2016a) Understanding heterogeneity in clinical cohorts using normative models: beyond case-control studies. Biol Psychiatry 80:552–561
Marquand AF, Wolfers T, Mennes M, Buitelaar J, Beckmann CF (2016b) Beyond lumping and splitting: a review of computational approaches for stratifying psychiatric disorders. Biol Psychiatry Cogn Neurosci Neuroimaging 1:433–447
Miettunen J, Nordstrom T, Kaakinen M, Ahmed AO (2016) Latent variable mixture modeling in psychiatric research—a review and application. Psychol Med 46:457–467
Milaneschi Y, Lamers F, Peyrot WJ, Abdellaoui A, Willemsen G, Hottenga J-J, Jansen R, Mbarek H, Dehghan A, Lu C, CHARGE Inflammation Working Group, Boomsma DI, Penninx BWHJ (2015) Polygenic dissection of major depression clinical heterogeneity. In press
Miller KL, Alfaro-Almagro F, Bangerter NK, Thomas DL, Yacoub E, Xu JQ, Bartsch AJ, Jbabdi S, Sotiropoulos SN, Andersson JLR, Griffanti L, Douaud G, Okell TW, Weale P, Dragonu J, Garratt S, Hudson S, Collins R, Jenkinson M, Matthews PM, Smith SM (2016) Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat Neurosci 19:1523–1536
Mirnezami R, Nicholson J, Darzi A (2012) Preparing for precision medicine. N Engl J Med 366:489–491
Mourao-Miranda J, Hardoon DR, Hahn T, Marquand AF, Williams SCR, Shawe-Taylor J, Brammer M (2011) Patient classification as an outlier detection problem: an application of the one-class support vector machine. Neuroimage 58:793–804
Mwangi B, Matthews K, Steele JD (2012) Prediction of illness severity in patients with major depression using structural MR brain scans. J Magn Reson Imaging 35:64–71
Rao A, Monteiro JM, Mourao-Miranda J, Alzheimers Dis I (2017) Predictive modelling using neuroimaging data in the presence of confounds. Neuroimage 150:23–49
Rasmussen CE, Williams C (2006) Gaussian processes for machine learning. MIT Press, Cambridge
Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-H, Holmans PA, Lee P, Bulik-Sullivan B, Collier DA, Huang H, Pers TH, Agartz I, Agerbo E, Albus M, Alexander M, Amin F, Bacanu SA, Begemann M, Belliveau RA Jr, Bene J, Bergen SE, Bevilacqua E, Bigdeli TB, Black DW, Bruggeman R, Buccola NG, Buckner RL, Byerley W, Cahn W, Cai G, Campion D, Cantor RM, Carr VJ, Carrera N, Catts SV, Chambert KD, Chan RCK, Chen RYL, Chen EYH, Cheng W, Cheung EFC, Chong SA, Cloninger CR, Cohen D, Cohen N, Cormican P, Craddock N, Crowley JJ, Curtis D, Davidson M, Davis KL, Degenhardt F, Del Favero J, Demontis D, Dikeos D, Dinan T, Djurovic S, Donohoe G, Drapeau E, Duan J, Dudbridge F, Durmishi N, Eichhammer P, Eriksson J, Escott-Price V, Essioux L, Fanous AH, Farrell MS, Frank J, Franke L, Freedman R, Freimer NB, Friedl M, Friedman JI, Fromer M, Genovese G, Georgieva L, Giegling I, Giusti-Rodriguez P, Godard S, Goldstein JI, Golimbet V, Gopal S, Gratten J, De Haan L, Hammer C, Hamshere ML, Hansen M, Hansen T, Haroutunian V, Hartmann AM, Henskens FA, Herms S, Hirschhorn JN, Hoffmann P, Hofman A, Hollegaard MV, Hougaard DM, Ikeda M, Joa I et al (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421–427
Ruiz FJR, Valera I, Blanco C, Perez-Cruz F (2014) Bayesian nonparametric comorbidity analysis of psychiatric disorders. J Mach Learn Res 15:1215–1247
Sato JR, Rondina JM, Mourao-Miranda J (2012) Measuring abnormal brains: building normative rules in neuroimaging using one-class support vector machines. Front Neurosci 6:178
Schnack H (2018) Improving individual predictions: machine learning approaches for detecting and attacking heterogeneity in schizophrenia (and other psychiatric disorders). Schizophr Res. In press
Schumann G, Binder EB, Holte A, De Kloet ER, Oedegaard KJ, Robbins TW, Walker-Tilley TR, Bitter I, Brown VJ, Buitelaar J, Ciccocioppo R, Cools R, Escera C, Fleischhacker W, Flor H, Frith CD, Heinz A, Johnsen E, Kirschbaum C, Klingberg T, Lesch K-P, Lewis S, Maier W, Mann K, Martinot J-L, Meyer-Lindenberg A, Mueller CP, Mueller WE, Nutt DJ, Persico A, Perugi G, Pessiglione M, Preuss UW, Roiser JP, Rossini PM, Rybakowski JK, Sandi C, Stephan KE, Undurraga J, Vieta E, Van Der Wee N, Wykes T, Maria Haro J, Wittchen HU (2014) Stratified medicine for mental disorders. Eur Neuropsychopharmacol 24:5–50
Sun H, Lui S, Yao L, Deng W, Xiao Y, Zhang W, Huang X, Hu J, Bi F, Li T, Sweeney JA, Gong Q (2015) Two patterns of white matter abnormalities in medication-naive patients with first-episode schizophrenia revealed by diffusion tensor imaging and cluster analysis. JAMA Psychiat 72:678–686
Torous J, Onnela JP, Keshavan M (2017) New dimensions and new tools to realize the potential of RDoC: digital phenotyping via smartphones and connected devices. Transl Psychiatry 7(3):e1053
Van Dijk KRA, Sabuncu MR, Buckner RL (2012) The influence of head motion on intrinsic functional connectivity MRI. Neuroimage 59:431–438
Van Essen DC, Smith SM, Barch DM, Behrens TEJ, Yacoub E, Ugurbil K, Consortium WU-MH (2013) The WU-minn human connectome project: an overview. Neuroimage 80:62–79
Varol E, Sotiras A, Davatzikos C, Alzheimer’s Disease Neuroimaging Initiative (2017) HYDRA: revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework. Neuroimage 145:346–364
Weinberger DR, Goldberg TE (2014) RDoCs redux. World Psychiatry 13:36–38
Wolfers T, Buitelaar JK, Beckmann C, Franke B, Marquand AF (2015) From estimating activation locality to predicting disorder: a review of pattern recognition for neuroimaging-based psychiatric diagnostics. Neurosci Biobehav Rev. In press
Wolfers T, Arenas AL, Onnink AMH, Dammers J, Hoogman M, Zwiers MP, Buitelaar JK, Franke B, Marquand AF, Beckmann CF (2017) Refinement by integration: aggregated effects of multimodal imaging markers on adult ADHD. J Psychiatry Neurosci 42:386–394
Young J, Ashburner J, Ourselin S (2013) Wrapper methods to correct mislabelled training data. 3rd international workshop on pattern recognition in neuroimaging. IEEE, Philadelphia
Zhang XM, Mormino EC, Sun NB, Sperling RA, Sabuncu MR, Yeo BT, Alzheimer’s Disease Neuroimaging Initiative (2016) Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer’s disease. Proc Natl Acad Sci U S A 113:E6535–E6544
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Marquand, A.F., Wolfers, T., Dinga, R. (2019). Phenomapping: Methods and Measures for Deconstructing Diagnosis in Psychiatry. In: Passos, I., Mwangi, B., Kapczinski, F. (eds) Personalized Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-030-03553-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-03553-2_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-03552-5
Online ISBN: 978-3-030-03553-2
eBook Packages: MedicineMedicine (R0)